TrialsgrambetaRCTs are beautiful

Psychosis and schizophrenia in adults: prevention and management (NICE guideline CG178)

This guideline cites 4 of the 62 landmark trials in our Psychiatry & psychotherapy register.

Issued by
NICE
Year
2014
Source
National Institute for Health and Care Excellence. Psychosis and schizophrenia in adults: prevention and management. NICE guideline [CG178]. Published 12 February 2014; last updated 18 March 2014; exceptional surveillance July 2025.

CG178 is the guideline that made cognitive behavioural therapy for psychosis (CBTp) and family intervention a universal offer rather than an optional extra: every adult with psychosis or schizophrenia should be offered both alongside antipsychotic medication. It also covers antipsychotic choice and the physical-health monitoring that goes with it, early intervention services, and clozapine in treatment-resistant illness. Its 2025 exceptional surveillance reviewed — and declined to add — metacognitive therapy. The 2014 CBTp and meta-analytic trials in our register appeared alongside or after the guideline and are listed separately.

Cognitive behavioural therapy for psychosis3

  • 2002SoCRATES⁠Psychiatry · Psychosis · First-episodeIn 315 first-episode psychosis patients, 5 weeks of CBT produced faster remission of auditory hallucinations and positive symptoms than supportive counselling or routine care.Read →
  • 2000Sensky CBT⁠Psychiatry · Psychosis · CBT for psychosisIn 90 patients with medication-resistant schizophrenia, 19 sessions of CBT produced more durable symptom improvement than a befriending control.Read →
  • 1997Kuipers CBTp⁠Psychiatry · Psychosis · CBT for psychosisIn 60 patients with medication-refractory psychotic symptoms, 9 months of individual CBT for psychosis produced higher 18-month improvement than standard care.50% vs 31%Read →

Antipsychotic pharmacotherapy1

  • 2005CATIE Core⁠Psychiatry · Psychosis · Pharmacology contextIn 1,493 patients with chronic schizophrenia, olanzapine, quetiapine, risperidone or ziprasidone achieved the same time to discontinuation as perphenazine, with most patients stopping treatment by 18 months.Read →

Published since the guideline3

  • 2014Morrison ACTION⁠Psychiatry · Psychosis · Antipsychotic refusersIn 74 patients with schizophrenia who declined antipsychotics, CBT alone reduced PANSS total compared with treatment as usual.Read →
  • 2014Jauhar CBTp⁠Psychiatry · Psychosis · Meta-analysisAcross 52 RCTs of CBT for psychosis, CBTp produced small reductions in positive and overall symptoms relative to active and inactive controls.Read →
  • 2014Turner MA⁠Psychiatry · Psychosis · Meta-analysisAcross 48 head-to-head psychosocial trials, CBT and social skills training achieved better symptom-specific outcomes than befriending or supportive comparators.Read →

Cited landmark trials not yet in the register4

Further landmark trials this guideline cites that are not (yet) covered in our register. Each links out to the study for further reading.

  • 2006CUtLASS

    First- vs second-generation antipsychotics showed no quality-of-life advantage.

  • 2008EUFEST

    Antipsychotics in first-episode schizophrenia across Europe.

  • 2005OPUS

    Integrated early-intervention treatment in first-episode psychosis.

  • 2013Leucht antipsychotics NMA

    Multiple-treatments meta-analysis of 15 antipsychotic drugs.

Every trial shown is one this guideline actually cites: each link was checked against the guideline's own reference list, and the few that a machine cannot match, a trial cited through a later follow-up, or a NICE guideline, which carries no DOI, were verified by hand against the full text. This is not the guideline's complete reference list, only the landmark trials it cites that our register holds.